- Home
- INVA vs AVAH Comparison
INVA vs AVAH Comparison
Compare INVA & AVAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INVA | AVAH |
|---|---|---|
| Founded | 1996 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.4B |
| IPO Year | 2000 | 2021 |
Fundamental Metrics
Financial Performance| Metric | INVA | AVAH |
|---|---|---|
| Price | $21.41 | $9.49 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 9 |
| Target Price | ★ $32.80 | $9.75 |
| AVG Volume (30 Days) | 727.2K | ★ 2.3M |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 816.67 | ★ 1850.00 |
| EPS | ★ 2.22 | 0.19 |
| Revenue | $217,217,000.00 | ★ $2,433,199,000.00 |
| Revenue This Year | $8.95 | $7.31 |
| Revenue Next Year | $12.65 | $5.59 |
| P/E Ratio | ★ $9.55 | $47.79 |
| Revenue Growth | ★ 62.63 | 20.19 |
| 52 Week Low | $16.52 | $3.73 |
| 52 Week High | $25.15 | $10.32 |
Technical Indicators
Market Signals| Indicator | INVA | AVAH |
|---|---|---|
| Relative Strength Index (RSI) | 41.01 | 59.37 |
| Support Level | $20.56 | $8.80 |
| Resistance Level | $22.86 | $9.86 |
| Average True Range (ATR) | 0.48 | 0.42 |
| MACD | -0.09 | -0.11 |
| Stochastic Oscillator | 18.15 | 49.07 |
Price Performance
Historical ComparisonAbout INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
About AVAH Aveanna Healthcare Holdings Inc.
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). The Private Duty Services segment generates the majority of revenue, which includes private duty skilled nursing services, non-clinical and personal care services, and pediatric therapy services, and is principally reimbursed by Medicaid and Medicaid MCO.